Heritage Square Durham $62M Deal

Investors eye Heritage Square in Durham for residential, life sciences project after $62M deal

bizjournals bizjournals | 1 year ago

A joint venture between Harrison Street, an investment management firm, national developer Sterling Bay, and real estate firm Acram Group is planning to transform the nearly 10-acre downtown site.

Investors eye downtown Durham for residential, life sciences project after $62M deal

bizjournals bizjournals | 1 year ago

A group of real estate investors could revitalize an aging retail center in downtown Durham by turning it into a life sciences and residential development.

commercialsearch commercialsearch | 2 years ago

Blackstone's subdivision will soon double its portfolio in the local market. The post BioMed Realty Pays $127M for Seattle Life Sciences Site appeared first on Commercial Property Executive.

Adaptive Reuse or New Construction? Considerations for Life Sciences

commercialsearch commercialsearch | 1 year ago

Consider these factor when determining which direction to pursue, says Justin Brasell and David Klein of Transwestern. The post Adaptive Reuse or New Construction? Considerations for Life Sciences appeared first on Commercial Property Executive.

Construction news, jobs and co... Construction news, j... | 1 year ago

The project known as the Refinery will create 121,000 sq ft of high spec, laboratory, research and development spaces under one roof. Located on the Northern Embankment of the River Thames, the project will include the extension and full reconfiguration of the existing four-storey building. Its façade and roof will be replaced, two new storeys added, and a green roof will finish the look of the building. During the project, Kier will support local small and medium enterprises (SMEs) through t...

£350m London Bridge life sciences hub advance

Construction news, jobs and co... Construction news, j... | 1 year ago

Guy’s & St Thomas’ Foundation selects developer for Snowsfields Quarter biosciences hub

After ‘Odd Year’ for Life Sciences, What’s Next?

propmodo propmodo | 1 year ago

In 2021, the life sciences sector had one of its best years on record. Already growing rapidly before the pandemic hit, the race to develop vaccines helped further bolster the niche sector, leading to a record number of IPOs formed last year. But 2022 has been different. The COVID-19 boost the industry benefited from has ended, and numbers are coming back down to Earth, looking more like they did pre-pandemic. Investment activity and venture capital funding have dropped significantly, and overal...

Houston's Life Sciences Push - THE TENANT ADVISOR

coydavidson coydavidson | 1 year ago

Texas Medical Center Announces TMC BioPort campus The Texas Medical Center announced plans for a 4th campus a massive biomanufacturing and medical supplies distribution center in Houston. TMC BioPort will be built on 500 acres south of Loop 610. The newest campus is still in the early stages of development. However, once completed, it’s expected to double the overall size of the medical center and create 100,000 jobs for the Greater Houston metro, TMC President and CEO Bill McKeon said during ...

kbs kbs | 1 year ago

Even before the pandemic, demand for life sciences had been building for almost 20 years. In 2020, pharma, R&D, and medical technology raced to procure vital medical products and solutions to develop new therapies and vaccines for COVID-19, which may have been the tipping point that led to the life sciences boom. In 2021, a record $78 billion of private equity and public investments was pumped into life science-related companies, up from $70 billion the year prior. Key life science...

forbes forbes | 1 year ago

Repositioning Properties For Life Sciences Tenants Comes With Long-Term Considerations The life sciences market continues to see increasing demand. getty The life sciences market continues to see increasing demand. The life sciences market is blazing hot, with record-setting venture capital investments flooding into the sector—$17 billion in the first half of 2021 alone. It’s no wonder investors are optimistic, with new innovations spurring the development ...